Product Information

BUPROPION HCL XL 300 MG TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.0982 per EA under NDC 42806041605. Its NADAC has been published 170 times since Aug 16, 2023.

FDA first approved this application on Jun 14, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 300 MG TABLET

bupropion hydrochloride
$0.0982per EA

Strength

300 mg/1

Manufacturer

Epic Pharma LLC

NDC

42806041605

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210015

FDA Approved

6/14/2018

TE Code

AB3

On Market Since

4/30/2023

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 300 MG TABLET has been published 170 times since Aug 16, 2023, and over the history we have for it it has declined 44.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.1988 (Feb 14, 2024)
All-time low$0.0982 (Oct 21, 2026)
52-week high$0.1385
52-week low$0.0982
Median price$0.1444
Average price$0.1424
Largest weekly change-27.4% (Feb 21, 2024)
Weeks tracked170
Tracking sinceAug 16, 2023

Price History

1W

0.0%

1M

-2.3%

3M

-5.7%

6M

-11.0%

1Y

-32.0%

3Y

-47.8%

5Y

N/A

All

-44.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 300 MG TABLET, manufactured by Epic Pharma LLC, is $0.0982 per EA (NDC 42806041605), effective Nov 11, 2026.

How has the price of BUPROPION HCL XL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 300 MG TABLET has declined 44.9%. It has been tracked across 170 weekly CMS publications since Aug 16, 2023.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 300 MG TABLET?

Since Aug 16, 2023, the NADAC for BUPROPION HCL XL 300 MG TABLET has ranged from a low of $0.0982 (Oct 21, 2026) to a high of $0.1988 (Feb 14, 2024), with a median of $0.1444 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 300 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 300 MG TABLET?

BUPROPION HCL XL 300 MG TABLET (NDC 42806041605) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.